Tissue vaccines and uses thereof

Details Tissue vaccines and uses thereof Tissue vaccines and uses thereof

2007-10-25

2011-11-22

Gussow, Anne M. (Department: 1643)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Cancer cell or component thereof

Reexamination Certificate

active

08062646

ABSTRACT:
Compositions comprising a tissue vaccine that include a mixture of heterogeneous tissue obtained from tumors and connective tissues. Vaccines comprising these compositions are also provided, as well as methods of using the vaccines in the treatment and/or inhibition of tumor growth, and particularly prostate tumor growth and cancers. The preparations may be defined as vaccines comprising tumor cells and connective (stromal) tissues derived from xenogeneic animals. Preparations comprising the tissue vaccines are provided using tissue harvested directly from tumors. Methods for preventing de novo development of cancer are also disclosed. A tissue vaccine comprising glutaraldehyde-(GFT) treated tissue prepared from tumor and connective tissue reduces the incidence of autochthonous prostate cancer. A tissue vaccine comprising a potassium thiocyanate extract (PTE) preparation of a tumor and connective tissue is also provided. The tissue vaccines are demonstrated to reduce the incidence of autochthonous prostate cancer.

REFERENCES:
patent: 6227368 (2001-05-01), Hiserodt et al.
patent: 6277368 (2001-08-01), Hiserodt et al.
patent: 6406689 (2002-06-01), Falkenberg et al.
patent: 6699483 (2004-03-01), Dalgleish et al.
patent: 2001/0006631 (2001-07-01), Hiserodt et al.
Dols, Smith, Meijer, Fox, Hu, Walker, Rosenheim, Moudgil, Doran, Wood, Seligman, Alvord, Schoof, and Urba. Vaccination of women with metastatic breast cancer using a costimulatory gene (CD80)modified, HLA-A2 matched allogeneic, breast cancer cell line: Clinical and Immunological Results. Human Gene Therapy, 2003. vol. 14 pp. 1117-1123.
Denmeade, Litvinov, Sokoll, Lilja, and Isaacs. Prostate specific antigen (PSA) protein does not affect growth of prostate cancer cells in vitro or prostate cancer xenografts in vivo. Prostate, 2003. vol. 56, pp. 45-53.
Frost and Sanderson. Tumor immunoprophylaxis in mice using glutaraldehyde-treated syngenic tumor cells. Cancer Research, 1975. vol. 35, pp. 2646-2650.
Peters, Brandhorst, and Hanna. Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors. Cancer Research, 1979. vol. 39, pp. 1353-1360.
Teir and Voutilainen. Effects of intraperitoneally injected suspensions of roentgen irradiated and non-irradiated tumor tissue on the growth of homologous tissue. Acta Pathol. Microbiol. Scand. 1957. vol. 40, pp. 273-282.
Boring CC, et al. (1993), Cancer statistics.CA Cancer J Clin, 43:7-26.
Nomura Amy et al. (2000),Cancer EpidBiomark Preγ, 9:883-87.
Brooks JD, et al. (2001),J Urol2001; 166:2034-8.
Hursting SD, et al. (1990),Preγ Med,19:242-53.
Gann PH. (1999),JAMA, 281:1682.
Gann PH, Ma J, Giovannucci E, et al. (1999),Cancer Res., 59:1225-30.
Tjoa BA, et al. (1999),Prostate; 40:125-29.
Tjoa BA, Murphy GP. (2000),Immunol Lett, 74:87-93.
Gulley J, et al. (2002),Prostate, 53:109-17.
Pollard M, Luckert PH. (1975),J Natl Cancer Inst, 54:643-49.
Suckow MA, et al. (1991),Lab Anim Sci., 41:151-56.
Ringler DH, Peter GK, Chrisp CE, et al (1985),Infect. Immun., 49:498-504.
Pollard M, Luckert PH. (1986),J Natl Cancer Inst., 77:583-87.
Pollard M, Luckert PH. (1987),Prostate, 11:219-27.
Pollard M. (1998),Prostate, 37:1-4.
Hrouda D, et al. (1998),Br J Urol., 82:870-76.
Hrouda D, et al. (2000),Br J UrolInt, 86:742-48.
Griffith TS, et al. (2001),J Natl Cancer Inst, 93:998-1007.
Charles LG, et al. (2000),World J Urol, 18:136-42.
Michael A, et al. (2005),Clin Cancer Res, 11:4469-78.
Wang et. al (1993), J. Clin. Invest., 91:684-692.
Shekhar et al. (2001), Cancer Res., 61:1320-1326.
Cunha et al. (2003),Mt. J. Cancer, 107:1-10.
Yu-quan Wei (2002),Anti-Cancer Drugs, 13:229-235.
Fong et al. (2001),J. Imm., 167: 7150-7156.
Srinivason et al. (2004),J. Translational Med., 2:1-12.
Bergman et al. (2003),Clin. Canc. Res., 9: 1284-1290.
Qui-ming He et al. (2003),J. Biol. Chem., 278 (24): 21831-21886.
Fernandez-Acerno MJ, et al. (2000),Cancer88: 1544-48.
Ohashi Y, et al. (2000),Anticancer Res., 20: 3025-30.
Furbert-Harris et al. (2003),Prostate, 57:165-175.
International Search Report, mailed Jul. 22, 2009 in PCT/US 09/35062.

Affiliated with

Also associated with

Rating

Tissue vaccines and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tissue vaccines and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tissue vaccines and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4277554